SELEGILINE News

← Back to News Overview

---

SELEGILINE currently has 0 news articles, with 16 predicted indications.

This page combines the AI-predicted indications for SELEGILINE with the latest health news. Indications highlighted in orange have recent news coverage.

Drug Information

• Evidence level: L5
• Predicted indications (16):
  • endogenous depression (99.0%)
  • unipolar depression (99.0%)
  • hereditary late onset Parkinson disease (99.0%)
  • early-onset parkinsonism-intellectual disability syndrome (99.0%)
  • juvenile onset Parkinson disease 19A (99.0%)
  • anxiety disorder (99.0%)
  • major depressive disorder (99.0%)
  • X-linked parkinsonism-spasticity syndrome (99.0%)
  • parkinsonian-pyramidal syndrome (99.0%)
  • Parkinson disease (99.0%)
  • atypical juvenile parkinsonism (99.0%)
  • hemiparkinsonism-hemiatrophy syndrome (99.0%)
  • polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis (99.2%)
  • schizophrenia (99.1%)
  • congenital disorder of glycosylation with defective fucosylation (99.0%)
  • retinal dystrophy with or without extraocular anomalies (99.0%)

View full drug report →

Related News (0)

No related news yet. When news mentions this drug, it will be collected and shown here automatically.

Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.